These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
620 related items for PubMed ID: 9380024
21. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Mooberry SL, Tien G, Hernandez AH, Plubrukarn A, Davidson BS. Cancer Res; 1999 Feb 01; 59(3):653-60. PubMed ID: 9973214 [Abstract] [Full Text] [Related]
22. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Kumar A, Soprano DR, Parekh HK. Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393 [Abstract] [Full Text] [Related]
23. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously. Gapud EJ, Bai R, Ghosh AK, Hamel E. Mol Pharmacol; 2004 Jul 15; 66(1):113-21. PubMed ID: 15213302 [Abstract] [Full Text] [Related]
24. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA. Biochemistry; 1997 Mar 25; 36(12):3554-62. PubMed ID: 9132006 [Abstract] [Full Text] [Related]
25. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. Canales A, Rodríguez-Salarichs J, Trigili C, Nieto L, Coderch C, Andreu JM, Paterson I, Jiménez-Barbero J, Díaz JF. ACS Chem Biol; 2011 Aug 19; 6(8):789-99. PubMed ID: 21539341 [Abstract] [Full Text] [Related]
26. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity. Tinley TL, Randall-Hlubek DA, Leal RM, Jackson EM, Cessac JW, Quada JC, Hemscheidt TK, Mooberry SL. Cancer Res; 2003 Jun 15; 63(12):3211-20. PubMed ID: 12810650 [Abstract] [Full Text] [Related]
27. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Chen JG, Horwitz SB. Cancer Res; 2002 Apr 01; 62(7):1935-8. PubMed ID: 11929805 [Abstract] [Full Text] [Related]
28. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Martello LA, McDaid HM, Regl DL, Yang CP, Meng D, Pettus TR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB, Horwitz SB. Clin Cancer Res; 2000 May 01; 6(5):1978-87. PubMed ID: 10815923 [Abstract] [Full Text] [Related]
29. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents. Nicoletti MI, Valoti G, Giannakakou P, Zhan Z, Kim JH, Lucchini V, Landoni F, Mayo JG, Giavazzi R, Fojo T. Clin Cancer Res; 2001 Sep 01; 7(9):2912-22. PubMed ID: 11555610 [Abstract] [Full Text] [Related]
30. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T. Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663 [Abstract] [Full Text] [Related]
31. Tubulin from paclitaxel-resistant cells as a probe for novel antimicrotubule agents. Sackett DL, Giannakakou P, Poruchynsky M, Fojo A. Cancer Chemother Pharmacol; 1997 Aug 01; 40(3):228-32. PubMed ID: 9219506 [Abstract] [Full Text] [Related]
32. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM. Cancer Res; 1995 Jun 01; 55(11):2325-33. PubMed ID: 7757983 [Abstract] [Full Text] [Related]
33. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. Klein LE, Freeze BS, Smith AB, Horwitz SB. Cell Cycle; 2005 Mar 01; 4(3):501-7. PubMed ID: 15711127 [Abstract] [Full Text] [Related]
34. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Honore S, Kamath K, Braguer D, Wilson L, Briand C, Jordan MA. Mol Cancer Ther; 2003 Dec 01; 2(12):1303-11. PubMed ID: 14707271 [Abstract] [Full Text] [Related]
35. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide. Paterson I, Naylor GJ, Wright AE. Chem Commun (Camb); 2008 Oct 14; (38):4628-30. PubMed ID: 18815706 [Abstract] [Full Text] [Related]
36. Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners. Nadaradjane C, Yang CH, Rodriguez-Gabin A, Ye K, Sugasawa K, Atasoylu O, Smith AB, Horwitz SB, McDaid HM. J Nat Prod; 2018 Mar 23; 81(3):607-615. PubMed ID: 29522336 [Abstract] [Full Text] [Related]
37. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Chu SW, Badar S, Morris DL, Pourgholami MH. Anticancer Res; 2009 Oct 23; 29(10):3791-6. PubMed ID: 19846910 [Abstract] [Full Text] [Related]
38. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB. Biochemistry; 2003 May 13; 42(18):5349-57. PubMed ID: 12731876 [Abstract] [Full Text] [Related]
39. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). Kowalski RJ, Giannakakou P, Hamel E. J Biol Chem; 1997 Jan 24; 272(4):2534-41. PubMed ID: 8999970 [Abstract] [Full Text] [Related]
40. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms. Wang Y, Yin S, Blade K, Cooper G, Menick DR, Cabral F. Biochemistry; 2006 Jan 10; 45(1):185-94. PubMed ID: 16388594 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]